Location History:
- Alexandria, VA (US) (2013)
- Washington, DC (US) (2014 - 2019)
- Evanston, IL (US) (2019)
- Boston, MA (US) (2021)
- Northbrook, IL (US) (2018 - 2023)
Company Filing History:
10 out of 2,118 
5 out of 5 
3 out of 3 
Years Active: 2013-2023
Title: The Innovations of Inventor Daniel R. Getts
Introduction: Daniel R. Getts, an accomplished inventor based in Northbrook, IL, has made significant contributions to the field of biomedical engineering and immunology. With a remarkable portfolio of 19 patents to his name, Getts is known for his innovative approaches to developing peptide-conjugated particles and particle-based immunological therapies.
Latest Patents: Among his latest inventions are two noteworthy patents. The first, titled "Peptide Conjugated Particles," provides compositions comprising peptide-coupled biodegradable poly(lactide-co-glycolide) (PLG) particles. This innovative technology allows for the surface-functionalization of PLG particles to facilitate the coupling of peptide molecules, which can be utilized in eliciting the induction of immunological tolerance. The second patent, "Covalent Polymer-Antigen Conjugated Particles," introduces compositions comprising tolerizing immune modified particles (TIMPs) and methods for their use and production. This invention emphasizes the covalent conjugation of carrier polymer with antigenic peptide prior to particle formation, ensuring exquisite control of particle size and antigen encapsulation for similar therapeutic purposes.
Career Highlights: Daniel R. Getts has worked with prestigious institutions such as Northwestern University and Cour Pharmaceuticals Development Company, Inc. His positions at these organizations have allowed him to lead groundbreaking research and develop innovative solutions in his field, further establishing his reputation as a leading inventor.
Collaborations: Throughout his career, Getts has collaborated with esteemed colleagues, including Lonnie D. Shea and Stephen D. Miller. These partnerships have enriched his work and facilitated advancements in the development of immunological therapies and related technologies.
Conclusion: With a robust portfolio of 19 patents and a career marked by significant innovations, Daniel R. Getts stands out as a leading figure in the realm of biomedical engineering. His pioneering work with peptide-conjugated particles showcases his commitment to advancing medical science and improving immunological treatments, solidifying his legacy as an influential inventor.